Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Insulin Resistance × Exercise Test × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Lung Neoplasms 7 Colorectal Neoplasms 5 Prostatic Neoplasms 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 2 Obesity 2 Neoplasms 2 Multiple Myeloma 2 Motor Activity 2 Lymphoma, Non-Hodgkin 2 Hematopoietic and Lymphoid System Neoplasm 2 Gastrointestinal Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Trastuzumab Cardiotoxicity 1 Sedentary Behavior 1 Sarcopenia 1 Polycystic Ovary Syndrome 1 Pelvic Neoplasms 1 Pathologically Proven Gastrointestinal Malignancy 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Myocardial Fibrosis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Malignant Solid Neoplasm 1

Interventions

Metformin 26 Pioglitazone 7 Exercise 7 Inositol 5 Insulin 4 Acupuncture Therapy 4 Ethinyl Estradiol 3 salicylsalicylic acid 2 drospirenone and ethinyl estradiol combination 2 Water 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Resistance Training 2 High-Intensity Interval Training 2 Folic Acid 2 Diet Therapy 2 Cyproterone Acetate 2 Caloric Restriction 2 ziprasidone 1 maltodextrin 1 lime 1 drospirenone 1 cinnulin PF 1 adrenosterone 1 World Health Organization oral rehydration solution 1 Waist-Hip Ratio 1 Waist Circumference 1 Vitamin D 1 Tirzepatide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05215223 2023-10-17

WBV

Cairo University

Phase NA Completed

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡